| GTO ID | GTC3233 |
| Trial ID | NCT05616468 |
| Disease | Nasopharyngeal Disease |
| Therapy | CAR-T cell |
| Treatment | BGT007 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | BGT007 Cell Treatment of Nasopharyngeal Carcinoma |
| Year | 2022 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Other ID(s) | BR-BGT-001 |
| Cohort 1 | |||||||||||
|
|||||||||||